Abstract:The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in maintaining multiorgan health and homeostasis. Endothelial functions in health include dynamic maintenance of vascular tone, angiogenesis, hemostasis, and the provision of an antioxidant, anti-inflammatory, and antithrombotic interface. Dysfunction of the vascular endothelium presents with impaired endothelium-dependent vasodilation, heightened oxidative stress, chronic inflammation, leukocyte adhesion and hyperpermeability, and endothelial cell senescence. Recent studies have implicated altered endothelial cell metabolism and endothelial-to-mesenchymal transition as new features of endothelial dysfunction. Endothelial dysfunction is regarded as a hallmark of many diverse human panvascular diseases, including atherosclerosis, hypertension, and diabetes. Endothelial dysfunction has also been implicated in severe coronavirus disease 2019. Many clinically used pharmacotherapies, ranging from traditional lipid-lowering drugs, antihypertensive drugs, and antidiabetic drugs to proprotein convertase subtilisin/kexin type 9 inhibitors and interleukin 1β monoclonal antibodies, counter endothelial dysfunction as part of their clinical benefits. The regulation of endothelial dysfunction by noncoding RNAs has provided novel insights into these newly described regulators of endothelial dysfunction, thus yielding potential new therapeutic approaches. Altogether, a better understanding of the versatile (dys)functions of endothelial cells will not only deepen our comprehension of human diseases but also accelerate effective therapeutic drug discovery. In this review, we provide a timely overview of the multiple layers of endothelial function, describe the consequences and mechanisms of endothelial dysfunction, and identify pathways to effective targeted therapies.Significance StatementThe endothelium was initially considered to be a semipermeable biomechanical barrier and gatekeeper of vascular health. In recent decades, a deepened understanding of the biological functions of the endothelium has led to its recognition as a ubiquitous tissue regulating vascular tone, cell behavior, innate immunity, cell-cell interactions, and cell metabolism in the vessel wall. Endothelial dysfunction is the hallmark of cardiovascular, metabolic, and emerging infectious diseases. Pharmacotherapies targeting endothelial dysfunction have potential for treatment of cardiovascular and many other diseases.

Studies on Common Pathogenesis Between Insulin Resistance and Endothelial Dysfunction

Insulin resistance and vascular endothelial dysfunction

The Role of Autophagy of Endothelial Cells in Diabetic Vascular Diseases

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target

Molecular Mechanisms and Clinical Insights

A Follow-up Study of the Relationship Between Endothelial Function and Insulin Resistance, Metabolic Syndrome in Obese Subjects

Abstract 452: Hyperglycemia and Oxidative Stress Impair Fluid Shear Stress-mediated Endothelial Nitric Oxide Synthase Phosphorylation and Activation Via Disrupting Adherens Junctions

Study on Relations Between Insulin Resistance and Cardiovascular Endocrinic Hormones in Elderly Patients with Essential Hypertension Metabolic Syndrome and NIDDM

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

Enos:A Key Factor Behind the Dysfunction of Endothelial Progenitor Cells in Diabetes Mellitus

Relationship Between Insulin and Endothelial Function

The crucial role and mechanism of insulin resistance in metabolic disease

Pathogenesis of Insulin Resistance and Prevention and Treatment Strategy of Integrated Traditional Chinese and Western Medicine

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction

Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction

Study of insulin resistance and insulin secretion function in overweight and obese subjects with endothelial dysfunction

The Effects of Antioxidant Supplementation on the Pathologic Mechanisms of Metabolic Syndrome and Cardiovascular Disease Development

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1

Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage